GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
C3924 2-fluoro Palmitic AcidSummary: inhibits sphingosine biosynthesis and long-chain acyl-CoA synthetase
-
C4236 FTY720 PhosphateSummary: sphingosine-1-phosphate (S1P) receptors agonist
-
C4064 W123Summary: S1P1 antagonist
-
C4287 ML-178Summary: S1P4 activator
-
C4797 TY 52156Summary: sphingosine-1-phosphate receptor 3 (SIP3) antagonist
-
C5098 CYM 5520Summary: noncompetitive allosteric agonist of S1P2
-
B5636 CS 2100Summary: S1P1 agonist
-
B5680 CYM 50260Summary: S1P4 agonist
-
B5681 CYM 50308Summary: S1P4 agonist
-
B5682 CYM 50358 hydrochlorideSummary: S1P4 antagonist